INTS6 anticorps (C-Term)
Aperçu rapide pour INTS6 anticorps (C-Term) (ABIN6257160)
Antigène
Voir toutes INTS6 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- INT6 Antibody detects endogenous levels of total INT6.
-
Homologie
- Pig,Bovine,Horse,Sheep,Rabbit,Dog
-
Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
-
Immunogène
- A synthesized peptide derived from human INT6, corresponding to a region within C-terminal amino acids.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:500-1:2000, ELISA(peptide) 1:20000-1:40000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Date de péremption
- 12 months
-
-
- INTS6 (Integrator Complex Subunit 6 (INTS6))
-
Autre désignation
- INTS6
-
Sujet
-
Description: Component of the Integrator (INT) complex, a complex involved in the small nuclear RNAs (snRNA) U1 and U2 transcription and in their 3'-box-dependent processing. The Integrator complex is associated with the C-terminal domain (CTD) of RNA polymerase II largest subunit (POLR2A) and is recruited to the U1 and U2 snRNAs genes (Probable). Mediates recruitment of cytoplasmic dynein to the nuclear envelope, probably as component of the INT complex (PubMed:23904267). May have a tumor suppressor role, an ectopic expression suppressing tumor cell growth (PubMed:15254679, PubMed:16239144).
Gene: INTS6
-
Poids moléculaire
- 117 kDa
-
ID gène
- 26512
-
UniProt
- Q9UL03
Antigène
-